İçeriğe geç
Global sound
Bluestock Talk

Bluestock Talk

FDA Doesn't Write Checks: A Conversation with Mark Domyahn

· 50 dk · Sezon 1 Bölüm 9

Bölüm notları

What happens when a MedTech company successfully gets through FDA?

That is often when the real work begins.

In this episode of Bluestock Talk, Allison is joined by reimbursement expert Mark Domyahn, Partner at JD Lymon Group (and Bluestocking Health Advisory Board member), to explore one of the most important (and frequently misunderstood) aspects of MedTech commercialization: getting paid.

As Mark explains, regulatory approval is only one piece of the puzzle. Hospitals, physicians, payers, and investors all evaluate new technologies differently, and increasingly, investors want to…

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
Radio 538 luisteren - Live!Şu an popüler